Wouter F. Tonnis
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems 4
- Food Science top 10%
-
- Inhalation and Respiratory Drug Delivery 6
-
- Pneumonia and Respiratory Infections 4
- Influenza Virus Research Studies 3
- Respiratory viral infections research 2
- Hepatitis B Virus Studies 2
-
- Protein purification and stability 3
-
- Crystallization and Solubility Studies 2
- Co-authors
- Wouter L.J. HinrichsHenderik W. FrijlinkJean‐Pierre AmorijGideon KerstenAnne H. de BoerKees van der Voort MaarschalkAnne JägerMaarten A. Mensink
- Journals
- Molecular Pharmaceutics (3 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)Journal of Controlled Release (2 papers)
- Partner nations
- NetherlandsGermanyChina
In The Last Decade
Wouter F. Tonnis
15 papers receiving 544 citations
Peers
Comparison fields: 5 of 80
- Pharmaceutical Science 193
- Food Science 93
- Immunology 107
- Pulmonary and Respiratory Medicine 152
- Biotechnology 37
Countries citing papers authored by Wouter F. Tonnis
This map shows the geographic impact of Wouter F. Tonnis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter F. Tonnis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter F. Tonnis more than expected).
Fields of papers citing papers by Wouter F. Tonnis
This network shows the impact of papers produced by Wouter F. Tonnis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter F. Tonnis. The network helps show where Wouter F. Tonnis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wouter F. Tonnis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 17 | |
| 2 | 2018 | 41 | |
| 3 | 2018 | 8 | |
| 4 | 2018 | 41 | |
| 5 | 2018 | 24 | |
| 6 | 2017 | 25 | |
| 7 | 2016 | 29 | |
| 8 | 2015 | 116 | |
| 9 | 2014 | 14 | |
| 10 | 2014 | 45 | |
| 11 | Powder to the people: the storage stability, handling, and administration advantages of powder formulations for pulmonary vaccination | 2014 | 1 |
| 12 | 2014 | 25 | |
| 13 | 2013 | 42 | |
| 14 | 2012 | 47 | |
| 15 | 2012 | 80 |
About Wouter F. Tonnis
Wouter F. Tonnis is a scholar working on Pharmaceutical Science, Epidemiology, Pulmonary and Respiratory Medicine, Infectious Diseases and Small Animals, having authored 15 papers that have together received 555 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (6 papers), Pneumonia and Respiratory Infections (4 papers), Drug Solubulity and Delivery Systems (4 papers), Influenza Virus Research Studies (3 papers), Protein purification and stability (3 papers), Respiratory viral infections research (2 papers), Crystallization and Solubility Studies (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Pharmaceutical Science (193 citations), Food Science (93 citations), Immunology (107 citations), Pulmonary and Respiratory Medicine (152 citations) and Biotechnology (37 citations). Wouter F. Tonnis has collaborated with scholars based in Netherlands, Germany and China. Frequent co-authors include Wouter L.J. Hinrichs, Henderik W. Frijlink, Jean‐Pierre Amorij, Gideon Kersten, Anne H. de Boer, Kees van der Voort Maarschalk, Anne Jäger, Maarten A. Mensink, Anke Huckriede and Huijun Chen. Their work appears in journals such as Molecular Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, Journal of Controlled Release, Acta Pharmaceutica Sinica B and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.